ITHANET logo trans600

Two new articles were added in IthaPedia under the Category Tag "Educational resources". The aim of this section is to create an online repository of educational articles, written by experts on the corresponding topic, that will be useful for both patients and scientists. The first two articles are entitled "The human hemoglobin molecule" (written by Henri Wajcman) and "Abnormal hemoglobins" (written by Henri Wajcman and Kamran Moradkhani).

 

More information: IthaPedia

NHLBI

The BABY HUG Treatment Study was designed to see if treatment with the drug hydroxyurea (also called HU) in children with sickle cell disease could prevent organ damage, especially in the spleen and kidneys. There was also a chance that treatment could prevent painful crises, lung disease, stroke, and blood infection.

 

More Information: clinicaltrials.gov, ITHANET Clinical Trials

 

 

 children hospital oakland

The primary aim of this study is to measure zinc status and related proteins in patients with Thalassemia who have or do not have diabetes. The secondary aim will be to explore the effect of zinc supplementation on glucose metabolism in patients with thalassemia. It is estimated that the study, which started in November 2012, will be completed in December 2014.

 

More information: clinicaltrials.gov, ITHANET Clinical Trials

rare disease day

February 28, 2013 marks the sixth international Rare Disease Day coordinated by EURORDIS and organised with rare disease national alliances in 24 European countries. On and around this day hundreds of patient organisations from more than 60 countries worldwide are planning awareness-raising activities converging around the slogan “Rare Disorders without Borders” Activities will take place across Europe, all the way to Russia, continuing to China and Japan, in the US and Canada, and as far as Australia and New Zealand!

 

Find out how to Get involved. Find out more about this year's theme.

For more information please visit the event's website.